Veterinary Biologics Market Trends, Drivers, and Regional Analysis 2025–2029

Uncover key drivers, emerging technologies, and competitive movements shaping the veterinary biologics market from 2025–2034 with trusted insights from The Business Research Company

How Is The Veterinary Biologics Market Size Expected To Expand Over 2029-2034?

Significant expansion has been observed within the veterinary biologics market in recent times, projecting a rise from a valuation of $12.67 billion in 2024 to $13.61 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.4%. This upward trajectory during the past period is largely traceable to factors such as the incidence of animal illnesses, supportive governmental regulations and established benchmarks, the increasing necessity for safe food provisions, the expansion of international commerce, and the substantial economic contribution made by livestock populations.

Projections indicate a robust expansion for the veterinary biologics sector over the ensuing years, with its market value anticipated to reach $18.36 billion by the year 2029, reflecting a compound annual growth rate (CAGR) of 7.8%. This upward trajectory throughout the projection timeframe is fueled by several key factors, notably the emergence of novel infectious ailments, shifting climate conditions impacting disease transmission, the adoption of precision techniques in livestock management, the growing influence of the one health paradigm, and escalating rates of pet ownership. During this same forecast period, several significant trends are expected to shape the market, such as the implementation of more extensive educational and professional development initiatives, a shift towards environmentally conscious and sustainable biological products, the deeper incorporation of digital health documentation systems, an increasing demand for biologics specifically for companion animals, and the development of treatment modalities that are both personalized and precisely focused.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12366&type=smp

Which Market Factors Are Fueling The Veterinary Biologics Industry Growth?

Escalating instances of animal-borne illnesses are projected to serve as a primary catalyst for the expansion within the veterinary biologics sector; these aforementioned animal diseases encompass a wide spectrum of ailments and health deteriorations impacting diverse animal populations, and the growing prevalence necessitates enhanced diagnostic and therapeutic interventions, which veterinary biologics, utilizing immunological principles for ailment management in animals, are designed to provide. To illustrate this trend, consider the figures reported in October 2022 by the European Center for Disease Prevention and Control, an agency situated in Sweden operating under the European Union, which documented 2,467 outbreaks of avian influenza across poultry populations, ultimately impacting approximately 48 million fowl, alongside 187 separate detections in captive avian species. Moreover, the global impact is starkly highlighted by data from July 2022, released by the World Health Organization, a United Nations specialized body headquartered in Switzerland, indicating that rabies is responsible for an annual loss of 59,000 human lives across more than 150 countries, with a disproportionate 95 percent of these fatalities occurring within the continents of Africa and Asia, thus underscoring how the rising incidence of animal pathology fuels the demand for veterinary biological solutions.

Which Categories Are Covered In The Veterinary Biologics Market Segmentation Analysis?

The veterinary biologics market covered in this report is segmented –

1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products

2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Diseases

3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels

4) By Application: Production Animal, Companion Animal

Subsegments:

1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines

2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits

3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants

4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums

5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids

Which Market Trends Are Expected To Define The Future Of The Veterinary Biologics Market?

Leading enterprises within the veterinary biologics sector are heavily invested in creating new biological agents, notably vaccines, intended to bolster animal well-being and proactively manage illnesses. Vaccines function by prompting the body’s defense mechanisms to identify and counteract particular disease-causing agents, thereby affording protective immunity against communicable ailments. As a concrete illustration, in August of 2024, Merck Animal Health, an internationally recognized animal health corporation situated in the United States, introduced a prototype autogenous vaccine specifically aimed at avian metapneumovirus (aMPV) type B, which subsequently secured approval from the U.S. Department of Agriculture (USDA) for its production and distribution. This vaccine, which resulted from a partnership with Cambridge Technologies, is engineered to tackle the serious respiratory complications attributed to aMPV type B in poultry populations, issues that have generated considerable financial detriment since the latter part of 2023. Manufactured at an advanced facility located in Minnesota, the preparation utilizes an oil-in-water emulsion base formulated precisely to lessen adverse tissue responses following inoculation, filling a crucial unmet need since no equivalent, officially licensed vaccines existed commercially until this point.

Which Organizations Are At The Forefront Of The Veterinary Biologics Market?

Major companies operating in the veterinary biologics market include Bayer AG, Eli Lilly & Company, Evonik Industries AG, Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Vetoquinol, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Ambrx Biopharma Inc., Adamis Pharmaceuticals Corporation, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., FidoCure, Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Which Geographic Areas Are Driving Strong Demand For The Veterinary Biologics Market?

North America was the largest region in the veterinary biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12366&type=smp

Browse Through More Reports Similar to the Global Veterinary Biologics Market 2025, By The Business Research Company

Veterinary Anesthesia Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anesthesia-equipment-global-market-report

Veterinary Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-diagnostic-equipment-global-market-report

Veterinary Disposables Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-disposables-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795